THERAPANACEA INC

Therapanacea Inc. specializes in custom computer programming services with a focused expertise in artificial intelligence-driven medical imaging solutions, particularly in the domain of AI contouring for radiotherapy planning. The company develops precision algorithms that automate the delineation of anatomical structures in CT and MRI datasets, enhancing treatment accuracy and reducing clinician workload. Their technical capabilities include deep learning model development, image segmentation, DICOM data integration, and HIPAA-compliant software deployment tailored to clinical workflows. A key differentiator is their ability to translate complex radiological requirements into robust, FDA-regulated software systems that operate reliably in high-stakes healthcare environments. The contractor has demonstrated direct engagement with the Department of Veterans Affairs, delivering AI-enabled tools that support veteran-specific oncology care pathways. Their work with the VA centers on improving radiation therapy planning efficiency and consistency across VA medical centers, suggesting a pattern of mission-aligned collaboration focused on enhancing clinical outcomes through automation. Therapanacea Inc. operates primarily within the custom computer programming services sector (NAICS 541511), positioning itself as a niche provider of AI software for clinical oncology applications. Their market focus is firmly on healthcare technology innovation, particularly in the intersection of artificial intelligence and radiation oncology, serving government healthcare providers who require secure, validated, and clinically integrated software solutions. As a small business structured as a 2L entity based in Cambridge, Massachusetts, Therapanacea Inc. leverages its proximity to academic medical centers and biotech innovation hubs to maintain technical agility. While currently holding no formal government certifications, the company’s geographic and operational footprint aligns it with the federal biomedical technology ecosystem, emphasizing R&D-driven delivery for mission-critical public health systems.